70 Participants Needed

Pregnancy and Contraception Education for Chronic Kidney Disease

(PACE-CKD Trial)

KB
Overseen ByKelcie Brophy
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: University of Michigan
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This pilot study will assess the efficacy of a pregnancy and contraception education decision aid (DA) for patients with chronic kidney disease to support decisions about reproductive health, and will assess feasibility and acceptability of the intervention to inform future Research Project Grant (R01) level studies.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Pregnancy and Contraception Education Decision Aid for chronic kidney disease?

Research shows that decision aids, which help patients understand their treatment options, can lead to better decision-making and outcomes. These aids help patients choose the right treatment for them, which can improve their adherence to the treatment and their overall health.12345

Is the Pregnancy and Contraception Education Decision Aid safe for people with chronic kidney disease?

The research does not provide specific safety data for the Pregnancy and Contraception Education Decision Aid, but it emphasizes the importance of personalized and safe contraception options for women with chronic kidney disease.23678

How is the treatment in the Pregnancy and Contraception Education for Chronic Kidney Disease trial different from other treatments for CKD?

This treatment is unique because it focuses on providing comprehensive reproductive counseling for women with chronic kidney disease (CKD), addressing the lack of consistent and adequate information about pregnancy and contraception. Unlike other treatments that may focus solely on medical management of CKD, this approach emphasizes informed decision-making and patient-centered care regarding reproductive health.267910

Research Team

AO

Andrea Oliverio, MD, MSc

Principal Investigator

University of Michigan

Eligibility Criteria

This trial is for patients with chronic kidney disease who are interested in making informed decisions about their reproductive health. Specific eligibility criteria have not been provided, but typically such trials require participants to be adults capable of consent and without conditions that might interfere with the study.

Inclusion Criteria

Able to speak and read English
I have been diagnosed with chronic kidney disease.
I have kidney problems for more than 3 months.

Exclusion Criteria

I have had a kidney transplant.
Patients that have significant cognitive or visual impairment that limits interaction with the decision aid (DA)
I am either surgically sterile or currently pregnant.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive either a novel decision aid about pregnancy and contraception in chronic kidney disease or currently available educational materials

1 day
1 visit (in-person)

Follow-up

Participants complete a survey about pregnancy and contraception decision making and the acceptability and feasibility of the educational materials

1 week
1 visit (virtual)

Long-term Follow-up

Nephrologists are anonymously surveyed after all patients have completed measures to assess acceptability and feasibility

12 months

Treatment Details

Interventions

  • Pregnancy and Contraception Education Decision Aid
Trial OverviewThe study is testing a special decision aid designed to help kidney disease patients understand their options regarding pregnancy and contraception. This will be compared to standard informational handouts. The goal is to see if the decision aid improves understanding and decision-making.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Intervention Group - Decision aidExperimental Treatment1 Intervention
Group II: Control Group -Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials
1,891
Recruited
6,458,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+

Findings from Research

Patients with end-stage renal disease can choose and change their treatment options, making the way information is presented crucial for their decision-making process.
Using structured 'patient decision aids' that follow simple principles can help patients make informed choices about dialysis options, leading to better treatment compliance and improved health outcomes.
How to select among dialysis options.Mooney, A.[2019]
A study involving 30 female patients with chronic kidney disease (CKD) and 12 nephrologists revealed a significant gap in reproductive health counseling, with patients expressing a strong desire for nephrologists to initiate discussions about reproductive health during kidney clinic visits.
Both patients and nephrologists identified the need for improved risk communication, with patients wanting a balance of risks and benefits while nephrologists focused on providing individualized risk estimates, highlighting the importance of tailored communication in reproductive counseling for CKD patients.
Supporting Patient-Centered Pregnancy Counseling in Nephrology Care: A Semistructured Interview Study of Patients and Nephrologists.Oliverio, AL., Lewallen, M., Hladunewich, MA., et al.[2023]
A new decision aid, consisting of a 50-minute video and an informational handbook, was developed to help patients with end-stage renal disease (ESRD) and their families understand treatment options for renal replacement therapy (RRT).
Preliminary evaluations showed that the materials were well-received and comprehensible, with the handbook written at a 4th to 6th grade reading level, making it accessible for patients with varying health literacy and cognitive abilities.
Development of a decision aid to inform patients' and families' renal replacement therapy selection decisions.Ameling, JM., Auguste, P., Ephraim, PL., et al.[2021]

References

How to select among dialysis options. [2019]
Supporting Patient-Centered Pregnancy Counseling in Nephrology Care: A Semistructured Interview Study of Patients and Nephrologists. [2023]
Development of a decision aid to inform patients' and families' renal replacement therapy selection decisions. [2021]
Use of a Supportive Kidney Care Video Decision Aid in Older Patients: A Randomized Controlled Trial. [2021]
Value of patient decision aids for shared decision-making in kidney failure. [2023]
The patient experience of kidney disease and pregnancy. [2020]
Ignorance is Not Bliss: The Case for Comprehensive Reproductive Counseling for Women with Chronic Kidney Disease. [2023]
Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology. [2022]
Feminizing care pathways: Mixed-methods study of reproductive options, decision making, pregnancy, post-natal care and parenting amongst women with kidney disease. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
Pregnancy and contraceptive counseling of women with chronic kidney disease and kidney transplants. [2022]